Skip to main content
. 2023 Feb 9;14:20406207231154708. doi: 10.1177/20406207231154708

Figure 1.

Figure 1.

Timeline of gemtuzumab-ozogamicin initial and reapproval by the United States Food and Drug Administration.

HHS Vulnerability Disclosure